Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Daiichi Sankyo Inc.
Current Parent Company: Daiichi Sankyo
Penalty: $300,000,000
Year: 2017
Date: August 1, 2017
Offense Group: safety-related offenses
Primary Offense: product safety violation
Secondary Offense: drug or medical equipment safety violation
Mega-Scandal: Pharmaceutical Hazards
Violation Description: Daiichi Sankyo agreed to pay $300 million to settle multi-district litigation alleging that the blood pressure drug Benicar caused gastrointestinal problems.
Level of Government: federal
Action Type: private litigation
Court: District of New Jersey
Civil or Criminal Case: civil
Case ID: MDL No. 2606
Case Name: In Re: Benicar (Olmesartan) Products Liability Litigation
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: Japan
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.